Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age
Apr 29, 2026, 13:25

Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age

Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:

“In transfusion medicine, prevention is always better than reaction.

One of the most critical yet often under-emphasized practices is extended phenotyping – especially for Rh (C, c, E, e) and Kell antigens in females.

Why does this matter?

Because alloimmunization doesn’t just affect a single transfusion – it can impact future pregnancies and neonatal outcomes.

A young female patient exposed to mismatched Rh or Kell antigens today may develop clinically significant antibodies tomorrow.

These antibodies can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), posing serious risks to both mother and baby.

By proactively providing Rh and Kell matched blood for females of childbearing age, we are not just ensuring safe transfusion – we are protecting future lives.

This is not just good practice.

It is responsible transfusion medicine.

Let’s move from compatibility to foresight.”

Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age

Stay updated with Hemostasis Today.